GO:0038095 Fc-epsilon receptor signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0038095 describes the signaling cascade triggered when immunoglobulin E (IgE) binds to Fc-epsilon receptors on the surface of effector cells such as mast cells and basophils.
• The high-affinity receptor Fc-epsilon-RI (FCER1A) is the principal initiator of this pathway, while the low-affinity receptor CD23 (FCER2) also contributes to IgE-mediated signaling.
• Proximal signaling events include receptor aggregation, Lyn kinase activation, and phosphorylation of ITAM motifs on the Fc-epsilon-RI beta and gamma subunits.
• Downstream effectors such as Syk, LAT, PLC-gamma, and MAPK cascades drive calcium flux, degranulation, and cytokine transcription.
• Dysregulation of this pathway is central to allergic diseases, asthma, and mast cell disorders, and has been implicated in cardiac remodeling through CD23-mediated cross-talk.
• CRISPR-based knockout, point-mutation, and knock-in models enable precise dissection of Fc-epsilon receptor signaling components in mast cells and other effector cells.
Description
The Fc-epsilon receptor signaling pathway (GO:0038095) is a biological process that begins when the Fc portion of immunoglobulin E (IgE) binds to an Fc-epsilon receptor on the surface of a target cell, and ends with the regulation of a downstream cellular process such as transcription. This pathway is best known for its role in allergic inflammation, where cross-linking of the high-affinity IgE receptor Fc-epsilon-RI on mast cells and basophils triggers rapid degranulation and release of histamine, leukotrienes, and cytokines. The receptor is a multimeric complex, and its signaling is tightly controlled by kinases and phosphatases that modulate the intensity and duration of the response. Beyond allergy, Fc-epsilon receptor signaling has been implicated in diverse physiological and pathological contexts, including cardiac remodeling through CD23-mediated signals and broader immune regulation beyond classical Th2 responses. Understanding the molecular steps of this pathway is therefore critical for researchers studying allergy, autoimmunity, and inflammation.
Fc-epsilon receptor signaling pathway At A Glance
| GO ID | GO:0038095 |
|---|---|
| GO term | Fc-epsilon receptor signaling pathway |
| Ontology | biological_process |
| Synonym | Fc-epsilon receptor signalling pathway |
| Major function | Transduces IgE-binding signals into cellular responses such as degranulation, cytokine production, and transcriptional regulation |
| Key receptors | High-affinity Fc-epsilon-RI (FCER1A) and low-affinity CD23 (FCER2) |
| Major cell types | Mast cells, basophils, eosinophils, and other effector cells |
| Downstream events | Calcium flux, MAPK activation, NF-kB and NFAT transcription factor activation |
| Disease relevance | Allergic asthma, atopic dermatitis, mastocytosis, and cardiac remodeling |
What Is GO:0038095?
According to the Gene Ontology, GO:0038095 (Fc-epsilon receptor signaling pathway) is defined as the series of molecular signals initiated by the binding of the Fc portion of immunoglobulin E (IgE) to an Fc-epsilon receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. The Fc portion of an immunoglobulin is its C-terminal constant region. This process encompasses receptor aggregation, activation of intracellular tyrosine kinases, calcium mobilization, and transcriptional changes that drive effector functions.
Why Is Fc-epsilon receptor signaling pathway Important in Cell Biology?
The Fc-epsilon receptor signaling pathway is a central mediator of allergic inflammation and an important target for therapeutic intervention. Its dysregulation contributes to asthma, allergic rhinitis, and mast cell activation disorders, and recent evidence links CD23-mediated signaling to cardiac remodeling, expanding its relevance beyond classical allergy. Understanding the precise molecular events of this pathway is essential for developing targeted therapies and for interpreting genetic variants that affect receptor function.
• Drives immediate hypersensitivity reactions through mast cell and basophil degranulation.
• Regulates transcription of pro-inflammatory cytokines and chemokines via NF-kB and NFAT.
• Modulates allergic asthma and atopic dermatitis pathogenesis.
• Involved in cardiac remodeling through CD23-mediated spleen-heart cross-talk.
• Serves as a target for anti-IgE therapies such as omalizumab.
• Provides a model for studying ITAM-based receptor signaling and kinase regulation.
• Contributes to host defense against parasites through IgE-mediated effector functions.
• Offers opportunities for CRISPR-based functional genomics of allergic pathways.
What Happens During Fc-epsilon receptor signaling pathway?
IgE Binding and Receptor Aggregation
In simple terms: IgE antibodies attach to receptors on the cell surface and pull them together, starting the signal.
The pathway is initiated when the Fc portion of IgE binds to the extracellular domain of the high-affinity Fc-epsilon receptor I (Fc-epsilon-RI) on mast cells and basophils. Monomeric IgE binding primes the cell, but receptor aggregation by multivalent antigens or anti-IgE antibodies is required for robust signaling. This aggregation brings the receptor-associated Lyn kinase into close proximity, enabling transphosphorylation of immunoreceptor tyrosine-based activation motifs (ITAMs) on the beta and gamma subunits of the receptor.
Proximal Kinase Activation and ITAM Phosphorylation
In simple terms: Enzymes add phosphate tags to the receptor, creating docking sites for the next signaling proteins.
Lyn kinase phosphorylates ITAM tyrosines on the Fc-epsilon-RI beta and gamma chains, recruiting Syk kinase via its tandem SH2 domains. Syk activation further amplifies the signal by phosphorylating adaptor proteins such as LAT and NTAL, which serve as scaffolds for multi-protein signaling complexes. The balance between Lyn-mediated positive and negative regulation is critical for controlling the intensity of the response.
Calcium Mobilization and Degranulation
In simple terms: The signal causes calcium to flood into the cell, which triggers release of histamine and other inflammatory molecules.
Downstream of LAT, phospholipase C-gamma (PLC-gamma) hydrolyzes phosphatidylinositol 4,5-bisphosphate to generate inositol trisphosphate (IP3) and diacylglycerol (DAG). IP3 triggers calcium release from intracellular stores, leading to calcium influx and activation of calcium-dependent effectors such as calmodulin and PKC. This calcium signal is essential for the fusion of secretory granules with the plasma membrane, resulting in the release of histamine, serotonin, and proteases.
Transcriptional Regulation and Cytokine Production
In simple terms: The signal reaches the nucleus and turns on genes that make inflammatory cytokines.
Activation of MAPK cascades (ERK, JNK, p38) and NF-kB and NFAT transcription factors leads to the transcription of genes encoding IL-4, IL-5, IL-13, TNF-alpha, and other mediators. This transcriptional response sustains and amplifies allergic inflammation and contributes to late-phase reactions. The pathway thus ends with the regulation of downstream cellular processes, as defined by GO:0038095.
Key Genes Involved in GO:0038095 Fc-epsilon receptor signaling pathway
The following genes and proteins are core components or regulators of the Fc-epsilon receptor signaling pathway, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FCER1A | High-affinity IgE receptor alpha subunit; binds IgE | Target for anti-IgE therapy and allergy studies |
| MS4A2 | Fc-epsilon-RI beta subunit; amplifies signaling via ITAM | Modulates receptor stability and signaling intensity |
| FCER1G | Fc-epsilon-RI gamma subunit; contains ITAM for Syk recruitment | Essential for receptor surface expression and signaling |
| FCER2 | Low-affinity IgE receptor CD23; regulates IgE synthesis and signaling | Implicated in cardiac remodeling and B cell regulation |
| LYN | Src-family kinase; phosphorylates ITAMs and regulates signaling | Key positive and negative regulator of Fc-epsilon-RI |
| SYK | Spleen tyrosine kinase; propagates ITAM signals | Central node for downstream calcium flux and degranulation |
| LAT | Adaptor protein; scaffolds signaling complexes | Required for PLC-gamma activation and calcium mobilization |
| PLCG1 | Phospholipase C-gamma 1; generates IP3 and DAG | Drives calcium release and PKC activation |
| MAPK1 | ERK2; regulates transcription of cytokines | Links receptor activation to gene expression |
| MAPK14 | p38 MAPK; stress-activated kinase | Controls cytokine production and inflammatory responses |
| NFKB1 | NF-kB subunit; transcription factor | Mediates inflammatory gene transcription |
| NFATC1 | NFAT transcription factor; calcium-dependent | Regulates cytokine gene expression |
| BTK | Bruton tyrosine kinase; involved in mast cell activation | Potential therapeutic target in allergy |
| PIK3CD | PI3K delta; modulates signaling and survival | Regulates mast cell responses |
| TNF | Pro-inflammatory cytokine; produced upon activation | Biomarker of allergic inflammation |
| IL4 | Th2 cytokine; induced by Fc-epsilon-RI signaling | Drives allergic inflammation and IgE class switching |
| IL13 | Th2 cytokine; effector of allergic responses | Therapeutic target in asthma |
How Is Fc-epsilon receptor signaling pathway Regulated?
Fc-epsilon receptor signaling is tightly regulated by a balance of kinases and phosphatases. Lyn kinase both initiates positive signals and recruits negative regulators such as SHP-1 and SHIP-1, which dephosphorylate ITAMs and limit the response. C-terminal tyrosine phosphorylation of Lyn modulates its activity, providing an additional layer of control. Calcium-dependent feedback and transcriptional regulation of pathway components further shape the intensity and duration of signaling.
Fc-epsilon receptor signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FCER1A | Allergic asthma, elevated IgE | Knockout mouse or human mast cell line (LAD2) |
| MS4A2 | Atopic dermatitis, asthma | Point-mutation knock-in in mast cells |
| FCER2 | Cardiac remodeling, B cell regulation | Conditional knockout mouse |
| LYN | Mast cell hyperactivation, autoimmunity | Kinase-dead knock-in |
| SYK | Inflammatory diseases, allergy | CRISPR knockout in RBL-2H3 cells |
Allergic Asthma and Atopic Dermatitis
Fc-epsilon receptor signaling is a primary driver of allergic asthma and atopic dermatitis. Activation of mast cells via Fc-epsilon-RI leads to the release of histamine, leukotrienes, and cytokines that cause bronchoconstriction and skin inflammation. Genetic variants in FCER1A and MS4A2 have been associated with elevated IgE levels and asthma susceptibility.
Mast Cell Activation Disorders
Mastocytosis and mast cell activation syndrome involve excessive or dysregulated mast cell degranulation, often linked to mutations in KIT but also influenced by Fc-epsilon receptor signaling components. Targeting proximal kinases such as Lyn and Syk is being explored as a therapeutic strategy.
Cardiac Remodeling
Recent evidence demonstrates that CD23 (FCER2)-mediated signaling contributes to spleen-heart cross-talk and promotes cardiac remodeling, expanding the role of Fc-epsilon receptor signaling beyond classical allergy. This suggests that IgE-CD23 interactions may influence cardiovascular pathology.
From Fc-epsilon receptor signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of FCER1A abolish IgE-mediated degranulation? | FCER1A knockout mast cell line (e.g., LAD2) |
| How does a specific ITAM mutation affect Syk recruitment? | Point-mutation knock-in of FCER1G ITAM tyrosines |
| Can a tagged Fc-epsilon-RI be used to track receptor internalization? | Knock-in of fluorescent tag on FCER1A |
| Does overexpression of Lyn enhance negative feedback? | Lyn overexpression in RBL-2H3 cells |
| What is the role of CD23 in cardiac fibroblasts? | CD23 knockout mouse model |
| Which genes are essential for mast cell cytokine production? | Genome-wide CRISPR library screening in mast cells |
How to Study the Fc-epsilon receptor signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptional changes | Identify cytokine genes induced by Fc-epsilon-RI |
| Phosphoproteomics | Tyrosine phosphorylation events | Map signaling networks downstream of Lyn/Syk |
| Calcium imaging | Intracellular calcium flux | Assess proximal signaling in live cells |
| Beta-hexosaminidase assay | Degranulation | Functional validation of CRISPR edits |
| Western blot | Protein phosphorylation and expression | Confirm knockout efficiency and pathway activation |
| Flow cytometry | Receptor surface expression | Measure FCER1A levels on mast cells |
| ELISA | Cytokine secretion | Quantify IL-4, TNF-alpha release |
| CRISPR library screening | Gene essentiality | Identify novel regulators of mast cell activation |
RNA-seq and Transcriptomics
RNA sequencing can profile transcriptional changes downstream of Fc-epsilon receptor activation, identifying cytokine and chemokine genes induced by IgE cross-linking. This method is useful for comparing wild-type and knockout mast cells to define pathway-specific gene signatures.
Phosphoproteomics
Mass spectrometry-based phosphoproteomics enables global mapping of tyrosine phosphorylation events following receptor aggregation, revealing novel substrates and feedback regulators such as Lyn and Syk. This approach can uncover signaling nodes not predicted by candidate-based studies.
Calcium Imaging
Live-cell calcium imaging using fluorescent dyes (e.g., Fura-2) measures the kinetics of calcium flux, a hallmark of Fc-epsilon receptor activation. This method is ideal for assessing the impact of CRISPR edits on proximal signaling.
Degranulation Assays
Beta-hexosaminidase release assays quantify mast cell degranulation in response to IgE cross-linking, providing a functional readout of the pathway. This is a standard method for validating knockout or knock-in phenotypes.
How CRISPR Can Be Used to Study GO:0038095 Fc-epsilon receptor signaling pathway
Knockout
CRISPR knockout of FCER1A, MS4A2, or FCER1G in mast cell lines (e.g., LAD2, RBL-2H3) abolishes IgE-mediated signaling and degranulation, providing definitive evidence for their essential roles. Knockout of LYN or SYK can reveal their contributions to both positive and negative regulation.
Point Mutation
Point mutations in ITAM tyrosines of FCER1G or in the kinase domain of LYN can be introduced via CRISPR to dissect specific phosphorylation events and their functional consequences. This approach is valuable for modeling human variants associated with allergic disease.
Knock-in
Knock-in of fluorescent or epitope tags on FCER1A or FCER2 allows real-time tracking of receptor trafficking and signaling complex assembly. Knock-in of reporter genes under cytokine promoters can monitor transcriptional activation downstream of the pathway.
Overexpression
Overexpression of wild-type or mutant Lyn, Syk, or CD23 in mast cells or other effector cells can amplify or dampen signaling, helping to establish causality and dose-dependent effects. This is particularly useful for studying negative feedback loops.
How EDITGENE Supports Fc-epsilon receptor signaling pathway Research
Researchers studying Fc-epsilon receptor signaling pathway-related genes often need to determine whether a candidate gene is causally involved in IgE-mediated responses or merely correlated with them. CRISPR-based models provide the gold standard for establishing causality, and EDITGENE offers a comprehensive suite of services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for Fc-epsilon receptor signaling pathway research.
Frequently Asked Questions About Fc-epsilon receptor signaling pathway
What is the Fc-epsilon receptor signaling pathway?
It is the series of molecular signals initiated by IgE binding to Fc-epsilon receptors on target cells, leading to cellular responses such as degranulation and cytokine production.
What genes are involved in Fc-epsilon receptor signaling?
Key genes include FCER1A, MS4A2, FCER1G, FCER2, LYN, SYK, LAT, and PLCG1.
What is the GO ID for Fc-epsilon receptor signaling pathway?
The GO ID is GO:0038095.
Which cells use Fc-epsilon receptor signaling?
Mast cells, basophils, eosinophils, and other effector cells express Fc-epsilon receptors and utilize this pathway.
How is Fc-epsilon receptor signaling regulated?
It is regulated by a balance of kinases such as Lyn and phosphatases like SHP-1 and SHIP-1, which control ITAM phosphorylation and signal duration.
What diseases are associated with Fc-epsilon receptor signaling?
Allergic asthma, atopic dermatitis, mastocytosis, and cardiac remodeling have been linked to this pathway.
What methods are used to study Fc-epsilon receptor signaling?
Common methods include RNA-seq, phosphoproteomics, calcium imaging, degranulation assays, and CRISPR screens.
Can CRISPR be used to study Fc-epsilon receptor signaling?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect pathway components.
What is the role of CD23 in Fc-epsilon receptor signaling?
CD23 (FCER2) is a low-affinity IgE receptor that regulates IgE synthesis and has been implicated in cardiac remodeling.
Why is Fc-epsilon receptor signaling important for drug discovery?
It is a validated target for anti-IgE therapies and kinase inhibitors in allergic diseases.
Conclusion
The Fc-epsilon receptor signaling pathway (GO:0038095) is a critical biological process that translates IgE binding into diverse cellular responses, from immediate degranulation to long-term transcriptional changes. Its dysregulation underlies allergic diseases and has emerging roles in cardiac pathology. CRISPR-based models are indispensable for dissecting the molecular players and for validating therapeutic targets. EDITGENE provides end-to-end services to support this research, from knockout cell lines to bioinformatics analysis.
References
- 1. Feng Y et al.. 2025. Spleen-Heart Cross-Talk Through CD23-Mediated Signal Promotes Cardiac Remodeling.. Circ Res 137(1):83-102 PMID: 40391441
- 2. Oliver JM et al.. 2004. Membrane receptor mapping: the membrane topography of Fc(epsilon)RI signaling.. Subcell Biochem 37:3-34 PMID: 15376617
- 3. Kinet JP. 1999. The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology.. Annu Rev Immunol 17:931-72 PMID: 10358778
- 4. Kambayashi T et al.. 2007. Proximal signaling events in Fc epsilon RI-mediated mast cell activation.. J Allergy Clin Immunol 119(3):544-52; quiz 553-4 PMID: 17336609
- 5. Izuhara K. 2017. Beyond Th2, more than ILC2.. Allergol Int 66(3):367-368 PMID: 28668290
- 6. Mossalayi MD et al.. 1997. CD23/Fc epsilon RII: signaling and clinical implication.. Int Rev Immunol 16(1-2):129-46 PMID: 9651789
- 7. Tolar P et al.. 2004. Positive and negative regulation of Fc epsilon receptor I-mediated signaling events by Lyn kinase C-terminal tyrosine phosphorylation.. Eur J Immunol 34(4):1136-45 PMID: 15048725
- 8. Kataoka T et al.. 2012. [Mast cell regulation].. Arerugi 61(6):805-12 PMID: 22868520
